Opportunity Information: Apply for RFA HL 16 024
Apply for RFA HL 16 024
- The HHS-NIH11 in the health sector is offering a public funding opportunity titled "NHLBI Outstanding Investigator Award (OIA) (R35)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233, 93.837, 93.838, 93.839,.
- This funding opportunity was created on Dec 10, 2015 and posted on Dec 10, 2015.
- Applicants must submit their applications by Apr 15, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NHLBI Outstanding Investigator Award (OIA) (R35) is a discretionary NIH grant opportunity from the Department of Health and Human Services, National Institutes of Health (HHS-NIH11), designed to support highly accomplished investigators working in heart, lung, blood, and sleep (HLBS) research. Its core aim is to boost scientific productivity and encourage innovation by giving established Program Directors/Principal Investigators long-term funding with more flexibility than typical project-by-project awards. In practical terms, the program is meant to let proven research leaders spend less time continuously competing for multiple separate grants and more time pursuing ambitious ideas, refining promising directions quickly, and responding to new opportunities as their science evolves.
This award specifically targets experienced PDs/PIs who already demonstrate sustained success and impact in NHLBI-supported science. A key eligibility expectation is that the applicant is currently the PD/PI on at least two NHLBI R01-equivalent awards, and has an outstanding research record that indicates a strong likelihood of making major contributions to HLBS fields. The emphasis is not simply on maintaining ongoing work, but on enabling investigators with demonstrated excellence to push their research programs forward in creative, potentially higher-risk, higher-reward ways using a stable support structure.
The funding mechanism is an R35, which generally signifies an investigator-focused award rather than a narrow, single-project framework. The opportunity lists an annual award ceiling of $500,000. While the source data does not specify the number of expected awards, the intent of the mechanism is clearly to concentrate meaningful support on investigators with exceptional track records, giving them the latitude to direct funds toward the most compelling scientific questions as they emerge.
A wide range of applicant organizations are eligible. These include public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), for-profit organizations other than small businesses, small businesses, and various governmental entities such as state, county, city or township governments, special district governments, and independent school districts. Eligible applicants also include Native American tribal governments (federally recognized) and Native American tribal organizations (other than federally recognized tribal governments), as well as public housing authorities and Indian housing authorities. The opportunity also references an “Others” category with additional eligibility details to be clarified in the full announcement text.
Administratively, the opportunity is identified as RFA-HL-16-024 and falls under the broad activity category of Health. It is associated with CFDA numbers 93.233, 93.837, 93.838, and 93.839, reflecting its alignment with NIH and NHLBI program areas. The funding opportunity was created and posted on December 10, 2015, and the listed closing date for applications was April 15, 2018 (both original and current closing dates match in the provided data).
Frequently Asked Questions (FAQs): NHLBI Outstanding Investigator Award (OIA) (R35)
What is the NHLBI Outstanding Investigator Award (OIA) (R35)?
The NHLBI Outstanding Investigator Award (OIA) is a discretionary NIH funding opportunity that uses the R35 mechanism to support highly accomplished investigators conducting heart, lung, blood, and sleep (HLBS) research. The goal is to provide long-term, flexible support to established research leaders.
Which federal agency offers this opportunity?
This opportunity is offered by the U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI). It is identified in the source as HHS-NIH11.
What is the main purpose of the OIA program?
The program is intended to boost scientific productivity and encourage innovation by giving proven investigators stable funding with more flexibility than typical project-by-project awards. It is designed to reduce the need to continuously compete for multiple separate grants and to enable faster pivots toward promising or emerging scientific directions.
What research areas does this award support?
The award supports research in heart, lung, blood, and sleep (HLBS) fields, consistent with NHLBI-supported science.
Who is this award intended for?
The OIA targets experienced Program Directors/Principal Investigators (PDs/PIs) who have a sustained record of success and impact in NHLBI-supported research and are considered likely to make major contributions to HLBS science.
What is a key eligibility expectation for investigators?
A key eligibility expectation stated in the provided information is that the applicant is currently the PD/PI on at least two NHLBI R01-equivalent awards, along with an outstanding research record.
Does the program emphasize maintaining existing work or pushing into new directions?
The emphasis is not simply on maintaining ongoing work. The intent is to enable investigators with demonstrated excellence to advance their research programs in creative ways, including potentially higher-risk, higher-reward approaches, using a stable support structure.
What does the R35 funding mechanism generally mean?
In general terms (as described in the provided information), an R35 signifies an investigator-focused award rather than a narrow, single-project framework. This implies greater flexibility for an investigator to direct resources toward the most compelling scientific questions as they emerge.
How much funding is available per year?
The opportunity lists an annual award ceiling of $500,000.
Is the number of awards specified?
No. The provided source data does not specify the number of expected awards.
What kinds of organizations are eligible to apply?
A wide range of organization types are listed as eligible, including:
- Public institutions of higher education
- Private institutions of higher education
- Nonprofit organizations (with or without 501(c)(3) status)
- For-profit organizations other than small businesses
- Small businesses
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Native American tribal governments (federally recognized)
- Native American tribal organizations (other than federally recognized tribal governments)
- Public housing authorities
- Indian housing authorities
What does the "Others" eligibility category mean?
The opportunity references an "Others" category, but the provided information indicates that additional eligibility details would need to be clarified in the full announcement text.
What is the funding opportunity ID?
The opportunity is identified as RFA-HL-16-024.
What activity category is associated with this opportunity?
The opportunity is listed under the broad activity category of Health.
Which CFDA numbers are associated with this opportunity?
The opportunity is associated with CFDA numbers 93.233, 93.837, 93.838, and 93.839.
When was this opportunity created and posted?
The opportunity was created and posted on December 10, 2015.
What was the application closing date?
The listed closing date for applications was April 15, 2018. The provided information indicates that both the original and current closing dates match.
What is the practical benefit to an investigator receiving this award?
Based on the provided description, the practical benefit is more time and flexibility to pursue ambitious ideas, refine promising research directions quickly, and respond to new opportunities as the science evolves, instead of repeatedly applying for multiple separate project grants.
Browse more opportunities from the same category: Health
Next opportunity: FY 2016 PRISM Notice of Funding Announcement
Previous opportunity: Understanding Barriers and Facilitators to Type 1 Diabetes Management in Adults (DP3)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HL 16 024
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HL 16 024) also looked into and applied for these:
| Funding Opportunity |
|---|
| Scaling Integrated, Effective and Sustainable Services for the Prevention of Mother to Child HIV Transmission (PMTCT) in the Republic of Uganda under PEPFAR Apply for CDC RFA PS10 10210501SUPP16 Funding Number: CDC RFA PS10 10210501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $2,458,270 |
| Provision of comprehensive, community-based HIV/AIDS Services and Capacity Building of Indigenous Organizations in the Republic of Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10180501SUPP16 Funding Number: CDC RFA PS10 10180501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $965,884 |
| Novel Genomic Technology Development (R21) Apply for PAR 16 015 Funding Number: PAR 16 015 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Ryan White HIV/AIDS Program Part D Grants for Coordinated HIV Services and Access to Research for Women, Infants, Children, and Youth (WICY) Supplemental Apply for HRSA 16 087 Funding Number: HRSA 16 087 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| AIDS Education and Training Center National Clinician Consultation Center Apply for HRSA 16 173 Funding Number: HRSA 16 173 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Global Noncommunicable Disease Prevention and Promotion of Health Apply for CDC RFA GH14 142003CONT16 Funding Number: CDC RFA GH14 142003CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement to Support the Establishment of a Southeast Asia Regional HIV Addiction Technology Transfer Center (ATTC) (Short Title: SE Asia Regional HIV ATTC) Apply for TI 16 004 Funding Number: TI 16 004 Agency: HHS-SAMHS Category: Health Funding Amount: $250,000 |
| Strengthening HIV Clinical Services within a Network of Public and Private Health Institutions in the West, South, and North West Departments of Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1711 Funding Number: CDC RFA GH16 1711 Agency: HHS-CDC-CGH Category: Health Funding Amount: $6,000,000 |
| National Stop Transmission of Polio (NSTOP) initiative supporting polio eradication in Africa Apply for CDC RFA GH15 161202CONT16 Funding Number: CDC RFA GH15 161202CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Drug-Free Communities (DFC) Support Program Apply for SP 16 001 Funding Number: SP 16 001 Agency: HHS-SAMHS Category: Health Funding Amount: $125,000 |
| Health Systems Strengthening (HSS) Mechanism Apply for RFA 685 16 000003 Funding Number: RFA 685 16 000003 Agency: USAID-SEN Category: Health Funding Amount: $37,000,000 |
| Advanced Nursing Education Program Apply for HRSA 16 070 Funding Number: HRSA 16 070 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Services Research for Autism Spectrum Disorder across the Lifespan II (ServASD II): Pilot Research on Services for Transition-Age Youth (R34) Apply for RFA MH 17 200 Funding Number: RFA MH 17 200 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Emergency Medical Services for Children State Partnership Regionalization of Care Apply for HRSA 16 050 Funding Number: HRSA 16 050 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Increasing Access to Medication-Assisted Treatment (MAT) in Rural Primary Care Practices (R18) Apply for RFA HS 16 001 Funding Number: RFA HS 16 001 Agency: HHS-AHRQ Category: Health Funding Amount: $1,000,000 |
| Novel Genomic Technology Development (R43/R44) Apply for PAR 16 016 Funding Number: PAR 16 016 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Planning Grant for Emerging Epidemic Virus Research Training for West African Countries with Widespread Transmission of Ebola- Guinea, Liberia, and Sierra Leone (D71) Apply for PAR 16 045 Funding Number: PAR 16 045 Agency: HHS-NIH11 Category: Health Funding Amount: $50,000 |
| Strengthening Care and Support Services for Orphans and Vulnerable Children and their Families, plus HIV Prevention for Youth in the Republic of Côte d’Ivoire Under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10290501SUPP16 Funding Number: CDC RFA PS10 10290501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $4,312,949 |
| Grants to Expand Care Coordination Targeted Capacity Expansion (TCE) through the Use of Technology Assisted Care (TAC) in Targeted Areas of Need (Short Title: TCE-TAC) Apply for TI 16 001 Funding Number: TI 16 001 Agency: HHS-SAMHS Category: Health Funding Amount: $280,000 |
| Licensure Portability Grant Program Apply for HRSA 16 014 Funding Number: HRSA 16 014 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HL 16 024", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.